1. WHO. Global tuberculosis report 2018. Geneva: World Health Organization;2018.
2. Kim JH. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis. 2015; 21:1913–1920.
Article
3. Cho KS, Park WS, Jeong HR, Kim MJ, Park SJ, Park AY, et al. Prevalence of latent tuberculosis infection at congregated settings in the Republic of Korea, 2017. Division of TB & HIV Control, Center for Disease Prevention, KCDC;2017.
4. Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015; 46:1563–1576.
5. Jagger A, Reiter-Karam S, Hamada Y, Getahun H. National policies on the management of latent tuberculosis infection: review of 98 countries. Bull World Health Organ. 2018; 96:173–184F.
Article
6. Park JS. The prevalence and risk factors of latent tuberculosis infection among health care workers working in a tertiary hospital in South Korea. Tuberc Respir Dis. 2018; 81:274–280.
Article
7. Yeon JH, Seong H, Hur H, Park Y, Kim YA, Park YS, et al. Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay. Sci Rep. 2018; 8:10113.
Article
8. Yoon CG, Oh SY, Lee JB, Kim MH, Seo Y, Yang J, et al. Occupational risk of latent tuberculosis infection in health workers of 14 military hospitals. J Korean Med Sci. 2017; 32:1251–1257.
Article
9. Lee KJ, Kang YA, Kim YM, Cho SN, Moon JW, Park MS, et al. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis. 2010; 42:672–678.
10. Lee SH. Diagnosis and treatment of latent tuberculosis infection. Tuberc Respir Dis (Seoul). 2015; 78:56–63.
Article
11. Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M. Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis. 2008; 12:498–505.
12. Park SH, Lee SJ, Cho YJ, Jeong YY, Kim HC, Lee JD, et al. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea. Korean J Intern Med. 2016; 31:517–524.
Article
13. Njie GJ, Morris SB, Woodruff RY, Moro RN, Vernon AA, Borisov AS. Isoniazid-rifapentine for latent tuberculosis infection: a systematic review and meta-analysis. Am J Prev Med. 2018; 55:244–252.
Article